Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

NCT02504619 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDUSTRY

Sponsor class

Stopped lack of recruitment

Conditions

Sickle Cell Disease
Thalassemia

Interventions

BIOLOGICAL: CordIn

Sponsor

Gamida Cell ltd